未分化复发性发热综合征(SURF)治疗反应预测因素与聚类分析
该研究纵向分析Eurofever登记库中101例未分化复发性发热综合征(SURF)患者,排除PFAPA及已知单基因周期性发热。秋水仙碱在77例中评估,61%完全应答;口腔阿弗他炎为秋水仙碱抵抗的独立预测因素(p=0.014)。IL-1抑制剂对难治病例有益,聚类分析揭示三个亚组。
要点
- SURF患者中约三分之一 sporadic 出现PFAPA样特征(淋巴结肿大、扁桃体炎、口腔阿弗他)。
- 秋水仙碱完全应答率61%(77例中),口腔阿弗他炎为抵抗独立预测因素(p=0.014)。
- IL-1抑制剂(阿那白滞素、卡那单抗)对难治性SURF病例有益。
核心结论
- SURF中存在秋水仙碱抵抗的预测因素,IL-1阻断显示出疗效,聚类分析提示SURF异质性,支持细化诊断标准和个体化治疗策略。
研究设计与样本
- 纵向分析Eurofever登记库中101例SURF患者,排除PFAPA、家族性地中海热及其他已知单基因复发性发热。
主要发现
- 常见症状包括发热、关节痛、腹痛和肌痛,PFAPA样特征(淋巴结肿大、扁桃体炎、口腔阿弗他)在三分之一病例中偶发出现。
- 秋水仙碱在77例中评估,61%获完全应答。
- 单变量分析显示口腔阿弗他炎(p=0.001)、颈部淋巴结肿大(p=0.012)和渗出性扁桃体炎(p=0.004)与秋水仙碱抵抗相关。
- 多变量分析确认口腔阿弗他炎为抵抗的独立预测因素(p=0.014)。
- 扁桃体切除术无效,IL-1抑制剂(阿那白滞素、卡那单抗)对难治性病例有益。
关键数值与推荐
- 秋水仙碱完全应答率61%(77例中评估)。
- 口腔阿弗他炎预测秋水仙碱抵抗的p=0.001(单变量)、p=0.014(多变量)。
- 颈部淋巴结肿大p=0.012、渗出性扁桃体炎p=0.004与秋水仙碱抵抗相关。
临床怎么用
- 作者认为IL-1阻断对难治性SURF病例有效。
- 作者认为聚类分析提示SURF异质性,支持细化诊断标准和个体化治疗策略。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Syndrome of undifferentiated recurrent fever (SURF) refers to a group of recurrent fevers without a clear monogenic cause. Clinical spectrum, treatment response predictors and management strategies remain unclear. OBJECTIVE: This study aims to longitudinally analyse a homogeneously selected cohort of 101 SURF patients, to identify factors associated with colchicine resistance and to evaluate the efficacy of interleukin-1 (IL-1) inhibitors. METHODS: Patients were enrolled in the Eurofever Registry, carefully excluding those with periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA); familial Mediterranean fever and other known monogenic recurrent fevers. Demographic, clinical and treatment data were analysed to identify predictors of colchicine resistance and define subgroups through cluster analysis. RESULTS: Common symptoms included fever, arthralgia, abdominal pain and myalgia, with PFAPA-like features (lymphadenopathy, tonsillitis, oral aphthae) observed in one-third of cases, sporadically. Colchicine efficacy, assessed in 77 patients, revealed complete response in the majority of patients (61%). Univariable analysis identified PFAPA-like features, including aphthous stomatitis (p=0.001), cervical lymphadenopathy (p=0.012) and exudative tonsillitis (p=0.004), as associated with colchicine resistance. Multivariable analysis confirmed aphthous stomatitis as an independent predictor of resistance (p=0.014). Tonsillectomy was ineffective. IL-1 inhibitors (anakinra, canakinumab) were beneficial in refractory cases. Cluster analysis revealed three distinct subgroups with varying symptoms and colchicine responses. CONCLUSIONS: These findings provide new insights into SURF, identifying predictors of colchicine resistance and supporting the efficacy of IL-1 blockade. Cluster analysis suggests the heterogeneity within SURF, reinforcing the need for refined diagnostic criteria and personalised treatment strategies.
引用
- Palmeri S, Ponzano M, Recchi G, et al. Predictive factors for therapeutic response and cluster analysis in syndrome of undifferentiated recurrent fever (SURF). RMD Open. 2025. PMID: 40784758. doi:10.1136/rmdopen-2025-005874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。